1. Prostacyclin and its stable analogue iloprost,1987
2. SEILER, S.M., BRASSARD, C.L., FEDERICI, M.E., BUCHANAN, J.O., ZAVOICO, G. B., FLEMING, J.S. and MEANWELL, N.A. 2-[3-[2-(4,5-diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393), a new, structurally-novel prostacyclin partial agonist: 1) inhibition of platelet aggregation and mechanism of action Thromb. Res. (previous paper).
3. Prostacyclin receptors in the cardiovascular system: potential selectivity from receptor subtypes or modified responsiveness;Keen;Eicosanoids,1989
4. Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2H-imidazo[4,5-b]quinolin-2-one (BMY-20844);Buchanan;Thromb. Res.,1989
5. On the identification and biological properties of prostaglandin;Mahmud;J. Prostaglandins Leukotr. Med.,1984